Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane plus Gemcitabine vs Gemcitabine in Metastatic Pancreatic Cancer
NCT00844649Phase 3Completed
- Sponsor
- Celgene Corporation
- Start
- Mar 2009
- Primary completion
- Sep 2012
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of nab-paclitaxel in pancreatic adenocarcinoma (PDAC), sponsored by Celgene Corporation. Started Mar 2009; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00844649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00844649.